Role of proteomics in diagnosis of cancer

Technology in Cancer Research and Treatment

Volumn 1, Issue 4, 2002, Pages 281-286

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

Biomarkers; Cancer diagnosis; Molecular diagnosis; Proteodiagnostics; Proteomics

Indexed keywords

ANNEXIN; MOLECULAR MARKER; NUCLEAR PROTEIN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0037547067     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460200100409     Document Type: Article

References (23)

1. Jain, K. K. Molecular Diagnostics: technologies, markets and companies. Jain PharmaBiotech Publications, Basel (2002).
2. Simone, N. L., Paweletz, C. P., Charboneau, L., et al. Laser capture microdissection: beyond functional genomics to proteomics. Mol. Diagn. 5, 301-7 (2000).
3. Jain, K. K. Proteomics: technologies, markets and companies. Jain PharmaBiotech Publications, Basel (2002).
4. Jain, K. K. Recent advances in oncoproteomics. Current Opinion in Molecular Therapeutics 4, 203-209 (2002).
5. Sinha, P., Kohl, S., Fischer, J., et al. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis 21, 3048-57 (2000).
6. Jain, K. K. Application of Laser Capture Microdissection to Proteomics. Methods in Enzymology 356, 157-167 (2002).
7. Fung, E. T., Wright, G. L. Jr, Dalmasso, E. A. Proteomic strategies for biomarker identification: progress and challenges. Curr. Opin. Mol. Ther. 2, 643-50 (2000).
8. Simpson, R. J., Dorow, D. S. Cancer proteomics: from signaling networks to tumor markers. Trends Biotechnol. 19, Suppl, S40-8 (2001).
9. Johnson, P. J. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J. Gastroenterol. Hepatol 14, Suppl, S32-6.
10. Celis, J. E., Wolf, H., Ostergaard, M. Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis 21, 2115-21 (2000).
11. Alaiya, A. A., Franzen, B., Hagman, A., et al. Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int. J. Cancer 98, 895-9 (2002).
12. Burchardt, M., Burchardt, T., Shabsigh, A., et al. Current concepts in biomarker technology for bladder cancers. Clin. Chem. 46, 595-605 (2000).
13. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577 (2002).
14. Zhai, G., Iskandar, M., Barilla, K., Romaniuk, P. J. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1. Biochemistry 40, 2032-40 (2001).
15. Luftner, D., Possinger, K. Nuclear matrix proteins as biomarkers for breast cancer. Expert Rev. Mol. Diagn. 2, 23-31 (2002).
16. Paweletz, C. P., Trock, B., Pennanen, M., et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: Potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Markers 17, 301-7 (2001).
17. Brunagel, G., Vietmeier, B. N., Bauer, A. J., et al. Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res. 62, 2437-42 (2002).
18. Nelson, P. S., Han, D., Rochon, Y., et al. Comprehensive analyses of prostate gene expression: convergence of expressed sequence tag databases, transcript profiling and proteomics. Electrophoresis 21, 1823-31 (2000).
19. Simone, N. L., Remaley, A. T., Charboneau, L., et al. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am. J. Pathol. 156, 445-52 (2000).
20. Ornstein, D. K., Gillespie, J. W., Paweletz, C. P., et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21, 2235-42 (2000).
21. Emmert-Buck, M. R., Gillespie, J. W., Paweletz, C. P., et al. An approach to proteomic analysis of human tumors. Mol. Carcinog. 27, 158-65 (2000).
22. Voss, T., Ahorn, H., Haberl, P., et al. Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int. J. Cancer 91, 180-186 (2001).
23. Brichory, F. M., Misek, D. E., Yim, A. M., et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. USA 98, 9824-9 (2001).